Vertex Pharmaceuticals
VRTX
#121
Rank
$133.07 B
Marketcap
$516.74
Share price
2.84%
Change (1 day)
38.30%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): $0.25 Billion USD

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are $10.33 Billion USD. In 2023 the company made an earning of $4.42 Billion USD, an increase over its 2022 earnings that were of $4.28 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.25 B-94.2%
2023 $4.42 B3.19%
2022 $4.28 B53.56%
2021 $2.79 B-12.06%
2020 $3.17 B118.45%
2019 $1.45 B120.64%
2018 $0.65 B1473.64%
2017 $41.86 M197.6%
2016 $14.06 M-102.97%
2015 -$0.48 Billion-28.46%
2014 -$0.67 Billion-51.5%
2013 -$1.37 Billion-30584.68%
2012 $4.47 M-95.47%
2011 $98.89 M
2009 -$0.6 Billion
2007 -$0.42 Billion83.1%
2006 -$0.23 Billion59.02%
2005 -$0.15 Billion3.28%
2004 -$0.14 Billion-38.16%
2003 -$0.23 Billion
2000 -$38.05 Million-20.38%
1999 -$47.78 Million31.62%
1998 -$36.3 Million91.05%
1997 -$19 Million-36.24%
1996 -$29.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$1.53 B 499.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.06 B 2,654.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.49 B 6,328.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.88 Billion-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.39 B 7,071.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.11 Billion-141.56%๐Ÿ‡บ๐Ÿ‡ธ USA